Back to Blog
Regulatory Updates••9 min read

FDA Reclassifies 12 Peptides: What April 2026's Policy Shift Means for Biohackers

The FDA's April 15, 2026 reclassification of 12 research peptides marks the most significant regulatory shift in the space since the 2023 compounding crackdown. Here's a breakdown of the affected compounds, the new compliance landscape, and how to think about your protocol going forward.

PeptIQ Research Team
Editorial
FDA Reclassifies 12 Peptides: What April 2026's Policy Shift Means for Biohackers
#Compounding#biohacking#FDA#BPC-157#Peptide Regulation#MOTS-C#2026 Policy#Peptide Compliance
Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections, calculate doses, access our peptide library, and optimize your protocols.

Download PeptIQ